We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SEZL:NASDAQSezzle Inc. Analysis

Data as of 2026-06-06 - not real-time

$116.01

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Sezzle Inc. (SEZL) is trading at $116.01, comfortably above its 20‑day SMA of 108.9 and the 50‑day SMA of 88.4, confirming a bullish price trend, yet the MACD shows a bearish crossover with a negative histogram and the RSI sits at 61, hinting at modest overbought pressure. Revenue surged 29.2% YoY to $135.5 million and GMV jumped 37.3%, driving a 41.9% rise in adjusted net income and an EPS of $5.10 that beat guidance, while the company lifted FY2026 revenue growth guidance to 30‑35%. The balance sheet reveals $120.4 million in cash against $145.2 million of debt, yielding a debt‑to‑equity of 73.8%, but the firm generates strong cash flow with $72.5 million free cash and a remarkable ROE of 92%. Valuation metrics are stretched: a trailing PE of 23.5 versus an industry average of 17, a PB of 19.8, and a DCF‑derived fair value of $77.2, placing the stock about 3.7% above fair value and classifying it as overvalued. Volatility is high at 71% over 30 days and beta is elevated at 2.39, reflecting sensitivity to market swings. Material news highlights robust earnings and upgraded guidance, but also flags a federal securities law investigation, adding regulatory uncertainty. Overall, the stock combines strong growth fundamentals with elevated valuation and risk factors, suggesting a nuanced outlook.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD signal and high short‑term volatility
  • Current price near but below resistance level
  • Regulatory investigation could trigger price pressure

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Strong revenue and earnings growth with raised guidance
  • High operating margins and robust cash generation
  • Market positioning in fast‑growing buy‑now‑pay‑later segment

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Sustained high ROE and margin profile
  • Elevated valuation multiples relative to peers
  • Persistent regulatory and market‑sensitivity risks

Key Metrics & Analysis

Financial Health

Revenue Growth29.20%
Profit Margin30.83%
P/E Ratio23.5
ROE91.95%
ROA47.54%
Debt/Equity73.79
P/B Ratio19.8
Op. Cash Flow$246.4M
Free Cash Flow$72.5M
Industry P/E17.0

Technical Analysis

TrendBullish
RSI61.2
Support$91.74
Resistance$123.04
MA 20$108.91
MA 50$88.35
MA 200$76.32
MACDBearish
VolumeStable
Fear & Greed Index83.02

Valuation

Fair Value$77.19
Target Price$120.33
Upside/Downside3.73%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta2.39
Volatility71.21%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.